# L-Citrulline in Patients With Post-Polio Syndrome

> **NCT02801071** · PHASE3 · COMPLETED · sponsor: **Dirk Fischer** · enrollment: 30 (actual)

## Conditions studied

- Post-Polio Syndrome

## Interventions

- **DRUG:** 15g L-citrulline daily p.o.
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02801071
- **Lead sponsor:** Dirk Fischer
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-14
- **Primary completion:** 2017-08-15
- **Final completion:** 2018-10-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801071, "L-Citrulline in Patients With Post-Polio Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02801071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*